SCHEMBL10047342

SCHEMBL10047342

COOC(=O)c1ccccc1S(=O)(=O)/N=C/c1ccc(C)cc1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 10/20 0.47
KDM4E B2RXH2 3/20 0.41
GAA P10253 3/20 0.41
HPGD P15428 2/20 0.41
POLB P06746 1/20 0.41
USP2 O75604 1/20 0.41
F2 P00734 1/20 0.40
PRSS1 P07477 1/20 0.40
PRSS2 P07478 1/20 0.40
PRSS3 P35030 1/20 0.40
CA1 P00915 1/20 0.40
CA2 P00918 1/20 0.40
CA5A P35218 1/20 0.40
CA9 Q16790 1/20 0.40
SMN1; SMN2 Q16637 1/20 0.38
LMNA P02545 4/20 0.37
MAPT P10636 5/20 0.37
KMT2A Q03164 3/20 0.36
HTT P42858 2/20 0.36
ATM Q13315 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12444229 0.90 CA1 (0.51) ALDH1A1KDM4EGAAHPGDPOLB
SCHEMBL13493932 0.83 F2 (0.51) ALDH1A1KDM4EGAAHPGDPOLB
SCHEMBL10047334 0.79 CA1 (0.50) ALDH1A1KDM4EGAAHPGDPOLB
SCHEMBL10047327 0.79 ALDH1A1 (0.51) ALDH1A1GAAPOLBF2PRSS1
SCHEMBL10073001 0.75 ALDH1A1 (0.51) ALDH1A1KDM4EGAAHPGDPOLB
SCHEMBL10073816 0.75 ALDH1A1 (0.47) ALDH1A1KDM4EHPGDPOLBSMN1; SMN2
SCHEMBL15975333 0.73 ALDH1A1 (0.49) ALDH1A1KDM4EGAAHPGDPOLB
SCHEMBL12096989 0.72 F2 (0.57) ALDH1A1KDM4EHPGDF2PRSS1
SCHEMBL12096988 0.72 F2 (0.57) ALDH1A1KDM4EHPGDF2PRSS1
SCHEMBL1933496 0.69 ALDH1A1 (0.69) ALDH1A1KDM4EGAAPOLBCA2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8093274-B2 Inhibitors of protein prenyltransferases THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2012-01-10 US disclosed
US-20100063114-A1 INHIBITORS OF PROTEIN PRENYLTRANSFERASES THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2010-03-11 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100063114-A1 INHIBITORS OF PROTEIN PRENYLTRANSFERASES GGT1, FNTA, FNTB ALDH1A1 1074/4885KDM4E 3350/4885GAA 436/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.